---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-029643"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:24:57.929117+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# ChromaDex shareholders elect all 8 director nominees, ratify auditor, and approve say-on-pay at 2024 annual meeting

## Summary
- All eight director nominees elected: Jaksch, Fried, Rubin, Yu, Ng, Patrick, Cohen, Shahbazi.
- Ratification of Marcum LLP as FY 2024 auditor passed with 49.6M for, 3.4M against, 83,650 abstain.
- Advisory approval of named executive officer compensation passed with 40.8M for, 0.9M against, 0.5M abstain.
- Broker non-votes of 10.9M reported for director election and say-on-pay proposals.

## SEC filing metadata
- accession: 0001628280-24-029643
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828024029643/0001628280-24-029643-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828024029643/cdxc-20240620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-029643
- JSON: https://secwatch.observer/filing/0001628280-24-029643.json
- Plain text: https://secwatch.observer/filing/0001628280-24-029643.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.